<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Endoscopic submucosal dissection (ESD), endoscopic mucosal resection (EMR), and partial circumference resection are used for large benign <z:mpath ids='MPATH_491'>polyps</z:mpath> to avoid an "Oncologic" Colorectal Resection (OCR); <z:mpath ids='MPATH_491'>polyps</z:mpath> with <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e> require OCR </plain></SENT>
<SENT sid="1" pm="."><plain>This review of <z:mpath ids='MPATH_491'>polyp</z:mpath> patients who had OCR was done to stratify <z:mpath ids='MPATH_491'>polyps</z:mpath> into risk groups to guide treatment </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Colonoscopy, operative, and pathology reports of patients with <z:mpath ids='MPATH_270'>adenoma</z:mpath> (+/- <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) who had OCR were reviewed </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_491'>Polyp</z:mpath> size, location, and pathology were assessed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Three hundred eighty-six <z:mpath ids='MPATH_491'>polyp</z:mpath> patients who had OCR were studied </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_491'>Polyp</z:mpath> locations were: right, 263 (68.1%); transverse, 33 (8.6%); sigmoid, 38 (9.8%); rectum, 23 (6.0%); and multiple sites, 13 (3.4%) </plain></SENT>
<SENT sid="6" pm="."><plain>The preoperative diagnosis was <z:mpath ids='MPATH_270'>adenoma</z:mpath> for 288 (74.6%) and dysplastic <z:mpath ids='MPATH_270'>adenoma</z:mpath> for 98 patients (25.4%) </plain></SENT>
<SENT sid="7" pm="."><plain>Final pathology revealed 62 invasive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (16.1%); 35% (34 out of 98) with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> preoperatively had <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> versus 9.7% (28 out of 288) with <z:mpath ids='MPATH_270'>adenoma</z:mpath> alone (p &lt; 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>The mean lymph node count was 16.0 ± 10.2 </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> stage breakdown was: stage 1, 74%; stage 2, 8.1%; stage 3, 16%; and stage 4, 1.6% </plain></SENT>
<SENT sid="10" pm="."><plain>The mean benign <z:mpath ids='MPATH_491'>polyp</z:mpath> size was 3.0 ± 1.9 versus 3.9 ± 2.4 cm for malignant <z:mpath ids='MPATH_491'>polyps</z:mpath> (p = 0.0008) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Over one out of three of dysplastic <z:mpath ids='MPATH_491'>polyps</z:mpath> and 10% of <z:mpath ids='MPATH_270'>adenomas</z:mpath> were <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancers</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>OCR is advised for dysplastic <z:mpath ids='MPATH_491'>polyps</z:mpath>; ESD, EMR, and wedge resection are appropriate for non-dysplastic <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
</text></document>